Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
$LLY ❖ Share of Americans who are considered overweight or obese has risen over the last 3 decades As obesity rates rise in the U.S. and worldwide, new weight-loss drugs surge in popularity https://t.co/EnFn4GChhx
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Medicare and obesity drugs, FDA syringe warnings, and more news.. https://t.co/qUPEszTTVt #pharma #obesity #weightloss #pandemic #WHO #antitrust #syringes #Medicare $NVO $LLY $BDX
$NVO $LLY Weight-Loss-Drug Users Pay Up for Help Ditching the Pricey Meds https://t.co/tYM1qkHouv
Shares of Eli Lilly ($LLY) and Novo Nordisk ($NVO) declined following comments by the CBO regarding obesity drugs. The market is evaluating the value of these drug makers amidst increasing obesity rates globally. Users of weight-loss drugs from these companies are willing to pay high prices for help in discontinuing the expensive medications.
